We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · June 12, 2019

Survival of T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy vs Mastectomy

Clinical Breast Cancer

 

Additional Info

Clinical Breast Cancer
T1-2N0M0 Triple Negative Breast Cancer Treated With Breast Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis
Clin. Breast Cancer 2019 May 30;[EPub Ahead of Print], H Li, Y Chen, X Wang, et al

Further Reading